Switzerland · What does BaseLaunch invest in?
BaseLaunch invests most often at Pre-seed (100% of the rounds on record), in sectors such as Healthtech, Connected-health and Digital-health.
BaseLaunch highlights
- 01
1 rounds on record
- 02
Mostly Pre-seed: 100% of its rounds
What they do
We partner with scientists and entrepreneurs to help launch and grow exceptional biotech ventures developing cutting-edge therapeutics. Up to CHF500,000 in financing.From their own website
- Type
- Accelerator (from a list, unverified)
- Cheque size
- Up to $500K as they say
- Stages
- Pre-seedSeedSeries A
- Sectors
- HealthtechConnected-healthDigital-health
- Based in
- Basel, Switzerland
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first1 appearances
- 2024
1 round
- Jun
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
8 of 16 we have independently watched raise
Alentis TherapeuticsAnaveonCancentusFimmcytePhialogicsSynendos TherapeuticsTolremo therapeuticsversamebCimeioEngimmuneMt-actOnenamedsPattern BioSciencesPharma BiomeT3 PharmaTepthera
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.